Department of Immunopathology, Division of Biomedical Science, Faculty of Medicine, Medical University of Lodz, Zeligowskiego 7/9 St, 90-752, Lodz, Poland.
BMC Pulm Med. 2023 Jun 17;23(1):212. doi: 10.1186/s12890-023-02514-4.
Despite numerous studies investigating vitamin D, its impact on asthma is still unknown. The aim of our meta-analysis is to analyze the vitamin D supplementation influence on asthma prevention and treatment ranging from gestational to adulthood period.
Fifteen randomized clinical trials were included after database search. Studies contained the analyzed endpoints: the number of asthma and wheezing occurrence in gestational and infantile periods, the change of childhood/adult asthma control test score and forced expiratory volume in one second (FEV1) in childhood and adulthood periods. Random effects model was used to calculate effect sizes.
Supplementation by women during pregnancy period decreased the wheezing occurrence in their children by 23% (RR = 0.77; 95% CI [0.64; 0.92]; p < 0.0049, I = 0%); whereas had no effect on given asthma parameters during the infantile period. Moreover, vitamin D administration had negative effect on the FEV1 change in children (MD = -3.84; 95% CI [-7.68; -0.01]; p = 0.0497; I = 95%), but had positive effect on the change of ACT score in adults (MD = 1.80; 95% CI [0.12; 3.49]; p = 0.0359; I = 99%).
Our meta-analysis showed the varying results depending on patient's life period. It is important to further investigate the role of vitamin D supplementation in asthma management.
尽管有许多研究探讨了维生素 D,但它对哮喘的影响仍不清楚。我们的荟萃分析旨在分析从妊娠期到成年期的维生素 D 补充对预防和治疗哮喘的影响。
通过数据库搜索,共纳入了 15 项随机临床试验。研究包含了分析终点:妊娠期和婴儿期哮喘和喘息发生的数量、儿童/成年哮喘控制测试评分和用力呼气量在儿童和成年期的变化。采用随机效应模型计算效应大小。
孕妇补充维生素 D 可使儿童喘息发生的几率降低 23%(RR=0.77;95%CI[0.64;0.92];p<0.0049,I=0%),但对婴儿期的哮喘参数无影响。此外,维生素 D 给药对儿童的 FEV1 变化有负面影响(MD=-3.84;95%CI[-7.68;-0.01];p=0.0497;I=95%),但对成人 ACT 评分的变化有积极影响(MD=1.80;95%CI[0.12;3.49];p=0.0359;I=99%)。
我们的荟萃分析显示,结果因患者的生命阶段而异。进一步研究维生素 D 补充在哮喘管理中的作用非常重要。